Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Urologic Oncology|November 18, 2018
Diagnosis and management of the growing teratoma syndrome: A single-center experience and review of the literaturePia Paffenholz, David Pfister, Vsevolod Matveev, et al.
Frontiers in Oncology|May 28, 2021
The Choice of Candidates in Survival Markers Based on Coordinated Gene Expression in Renal CancerNatalya Apanovich, Pavel Apanovich, Danzan Mansorunov, et al.
Diagnostics (Basel, Switzerland)|January 16, 2020
The Genes-Candidates for Prognostic Markers of Metastasis by Expression Level in Clear Cell Renal Cell CancerNatalya Apanovich, Maria Peters, Pavel Apanovich, et al.
Urologic Oncology|May 1, 2013
Effect of the timing of orchiectomy on survival in patients with metastatic germ cell tumors of testisMikhail Fedyanin, Alexey Tryakin, Anatoly Bulanov, et al.
Central European Journal of Urology|February 8, 2021
Expression of growth factors and their receptors in the primary renal cell carcinoma: new data and reviewMaria Volkova, Ilya Tsimafeyeu, Anna Olshanskaya, et al.
American Journal of Clinical and Experimental Urology|April 5, 2021
Immunochemical expression of fibroblast growth factor and its receptors in primary tumor cells of renal cell carcinomaMaria Volkova, Ilya Tsimafeyeu, Anna Olshanskaya, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2023
Smoking Cessation After Diagnosis of Kidney Cancer Is Associated With Reduced Risk of Mortality and Cancer Progression: A Prospective Cohort StudyMahdi Sheikh, Anush Mukeriya, Hana Zahed, et al.
Journal of Cancer Research and Clinical Oncology|July 6, 2018
Dose-reduced first cycle of chemotherapy for prevention of life-threatening acute complications in nonseminomatous germ cell tumor patients with ultra high tumor markers and/or poor performance statusAlexey Tryakin, Mikhail Fedyanin, Anatoly Bulanov, et al.
Asia-Pacific Journal of Clinical Oncology|July 3, 2024
PRIORITI: Phase 4 study of triptorelin or active surveillance in high-risk prostate cancerVsevolod Matveev, Xin Gao, Evgeny Kopyltsov, et al.
European Urology|December 11, 2013
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancerAxel Heidenreich, Patrick J Bastian, Joaquim Bellmunt, et al.
Pageof 5